Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
Culture remains at the heart of care
NAIDOC Week honours the enduring strength, depth of knowledge and the rich culture of Aboriginal and Torres Strait Islander peoples.
Inside a multidisciplinary antenatal vaccination clinic
To protect pregnant women and their unborn babies from the severe adverse outcomes associated with the virus, the first pharmacist-led COVID-19 vaccination clinic for pregnant women opened in Western Australia’s King Edward Memorial Hospital on 20 September.
The impact of air pollution
Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...
Psychotropic self-poisoning on the rise in youth
A new retrospective cohort study has found that self-poisoning, by ingesting psychotropic medicines, in Australian children and adolescents is increasing. The prescribed medicines...
2018 PSA Offshore Refresher Conference
Delegates from the 43rd annual PSA Offshore Refresher conference have recently returned from host city San Francisco, where they networked while learning about the...













